Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 16,043 $ 24,550
Accounts receivable and contract asset 12,921 13,883
Prepaid expenses and other current assets 2,172 1,764
Total current assets 31,136 40,197
Property and equipment, net 15,346 16,556
Operating lease right-of-use assets 882 556
Goodwill 2,811 1,379
Intangible assets, net 14,540 249
Other assets 1,605 1,634
Total assets 66,320 60,571
Current liabilities    
Accounts payable 1,192 1,179
Deferred revenue, short-term 24,174 26,360
Accrued expenses and other current liabilities 5,613 4,885
Total current liabilities 30,979 32,424
Deferred revenue, long-term 405 598
Other liabilities 631 298
Total liabilities 32,015 33,320
Commitments and contingencies (Note 19)
Stockholders' equity    
Preferred stock: $0.005 par value; 20,000,000 shares authorized; no shares issued and outstanding as of December 31, 2020 and 2019
Common stock: $0.005 par value; 500,000,000 shares authorized; 11,538,998 and 11,314,150 shares issued and outstanding as of December 31, 2020 and 2019, respectively 58 57
Additional paid-in capital 128,771 122,907
Accumulated deficit (94,354) (95,579)
Accumulated other comprehensive loss (170) (134)
Total stockholders' equity 34,305 27,251
Total liabilities and stockholders' equity $ 66,320 $ 60,571